Halifax-based Densitas Inc. whose software helps assess the density of breasts during mammograms, announced this week its densitas densityai software will soon be available on the Nuance AI Marketplace.
In a statement, Densitas said the Nuance marketplace provides access to more than 70 percent of all radiologists across the largest network of connected healthcare facilities in the U.S.
“AI can play an important supporting role for radiologists by automating routine, time-consuming, subjective and fatiguing tasks so that they can focus on more challenging interpretive tasks,” said Woojin Kim, chief medical information officer at the Healthcare Division of Nuance Communications.
“What sets densitas densityai apart is that it has been thoughtfully designed to process routinely archived mammograms so that breast density assessments can be obtained from historical studies when comparing current with prior exams.”
Densitas densityai delivers automated breast density assessments from standard digital imaging in the medical community. The Densitas software provides an automated mechanism for quantifying and recording breast tissue density, a risk factor for breast cancer in women. Dense breasts can mask cancerous cells. Dense breast tissue is also linked to higher chances of cancer.
As well as speeding and simplifying the process of quantifying breast density, the Densitas technology standardizes the density measurement and enables stratification of women to ensure those who need more aggressive follow-up receive it.
Approved by the Food and Drug Administration, the densitas densityai solution uses artificial intelligence to align with how the human eye processes breast images in mammograms. It rapidly generates reproducible and standardized breast density assessments.
Densitas recently announced that densitas densityai has also been selected for use in a major breast screening trial in Germany.